10 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 14.5% per year over the past 5 years.
Operating margin has expanded, at -11.3% in the latest year.
Financial health
Total debt has grown slower than revenue (-96.8% vs -14.5% per year).
The company is unprofitable; at its current free-cash-flow burn it has roughly 1.4 years of cash runway.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$19M
-$2M
62.4%
-11.3%
-$2M
—
$2M
2024
$19M
-$4M
61.6%
-17.0%
-$542807
—
$2M
2023
$24M
-$23M
62.0%
-93.1%
-$5M
$9
$2M
2022
$35M
-$70M
63.1%
-221.1%
-$16M
$125491
$7M
2021
$44M
-$23M
67.4%
-44.1%
-$14M
$108985
$26M
2020
$42M
$13M
63.0%
-42.0%
—
$264367
$15M
2019
$24M
-$51M
61.4%
-62.6%
—
—
$5M
2018
$459091
$62834
77.3%
-391.4%
—
—
$4M
2017
$4M
-$1M
69.7%
-30.4%
—
—
$284246
2016
$2M
-$4M
20.3%
-191.4%
—
—
$34258
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$6M
-$797978
57.7%
-14.2%
—
—
$3M
Dec '25
$5M
-$283131
59.8%
-5.7%
-$977266
—
$3M
Sep '25
$5M
-$679968
58.8%
-14.5%
-$243553
—
$2M
Jun '25
$5M
-$895272
61.5%
-19.6%
-$705675
—
$1M
Mar '25
$5M
-$480757
62.3%
-10.2%
-$204983
—
$2M
Dec '24
$5M
$15095
66.5%
-1.7%
-$482336
—
$2M
Sep '24
$5M
-$152799
53.9%
-6.9%
$157377
—
$2M
Jun '24
$5M
$459737
65.8%
-7.4%
$289779
—
$2M
Mar '24
$4M
-$3M
59.0%
-35.4%
-$699448
—
$2M
Dec '23
$5M
-$996501
66.2%
-19.8%
-$290515
$0
$2M
Sep '23
$6M
-$16M
62.1%
-266.5%
-$383681
$9
$2M
Jun '23
$6M
-$2M
62.8%
-29.8%
-$342962
$819
$3M
Mar '23
$6M
-$1M
64.4%
-22.4%
-$2M
$0
$2M
Dec '22
$6M
-$4M
58.6%
-66.5%
-$2M
$0
$3M
Sep '22
$8M
-$15M
63.2%
-190.6%
-$2M
$125491
$7M
Jun '22
$9M
-$32M
69.0%
-385.5%
-$2M
$127949
$10M
Mar '22
$10M
-$5M
66.9%
-52.0%
-$5M
$77732
$13M
Dec '21
$9M
-$19M
53.6%
-269.7%
-$6M
$93489
$20M
Sep '21
$10M
-$3M
58.6%
-71.6%
-$4M
$108985
$26M
Jun '21
$11M
$2M
68.1%
-63.2%
—
$124226
$19M
Valuation over time
How the market has priced YCBD against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has risen from 0.1× (Mar '23) to 0.4× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is YCBD growing its revenue and profit?
Over the past 5 years, cbdMD, Inc.'s revenue has declined 14.5% per year. These are computed facts, not advice.
How much debt does YCBD have?
As of FY2025, cbdMD, Inc. reported — of total debt against $2M of cash.
What is YCBD's profit margin?
In FY2025, gross margin was 62.4%, operating margin -11.3%, and net margin -10.6%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.